Infliximab and Intravenous Gammaglobulin in Hospitalized Severe COVID-19 Patients in Intensive Care Unit.

Mohsen FarrokhpourNader RezaieNajmeh MoradiFatemeh Ghaffari RadShirin IzadiMehdi AzimiFarhad ZamaniShahrokh IzadiMitra RanjbarMahin Jamshidi MakianiAzadeh LaaliMaryam RohamMahdi Yadollahzadeh

Published in: Archives of Iranian medicine (2021)

According to the findings of this study, it seems that infliximab and IVIg, alone or together, in patients with severe COVID-19 disease can be considered an effective treatment.

Keyphrases

intensive care unit
sars cov
coronavirus disease
early onset
ulcerative colitis
high dose
mechanical ventilation
low dose
respiratory syndrome coronavirus
combination therapy
acute respiratory distress syndrome